¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21
±³À°ÀÏÀÚ : 2022-05-21
±³À°Àå¼Ò : ´ë¿õÁ¦¾à º£¾îȦ  
±³À°ÁÖÁ¦ : Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª
ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹°£¿Ü°ú¿¬±¸È¸  
´ã´çÀÚ : ±èÀºÈñ
¿¬¶ôó : 02-2135-2279  
À̸ÞÀÏ : office@thekalis.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-21 º£¾î Ȧ 13:00~13:15 Indication setting for each approach for the beginner; Which approach should we use?  ÇÑ¿µ¼®(°æºÏÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 13:15~13:30 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 13:30~13:45 Each tip for glissonean pedicle approach in conventional and minimally invasive approach  ±èÁöÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
Åä·Ð 05-21 º£¾î Ȧ 13:45~14:00 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 14:00~14:15 The short-cut to shorten learning curve for liver surgery.  ÇÑ´ëÈÆ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 14:15~14:30 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 14:30~15:00 Junior & Fellow ȸ¿ø ¼Ò°³  ÃÖ±âÈ«(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 15:00~16:00 Video presentation  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ05-21 º£¾î Ȧ 16:00~16:10   () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:10~16:30 Current status of liver diseases including HCC in Korea  À¯¼öÁ¾(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:30~16:45 Working definition of resectable HCC?  ¹Ú¹Î¼ö(°æÈñÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:45~17:00 Recent updates of ablative therapies: RFA vs. MWA  À̹οì(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:00~17:15 TACE vs. Brigding TACE before Surgery  ¹Ú¿µ¸ñ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:15~17:30 Initial LT vs. Salvage LT  ÃÖ±Ô¼º(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:30~17:45 Role of adjuvant therapies after initial treatment for HCC  Á¶ÀºÁÖ(¼­¿ïÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 17:45~18:00 Case discussion  ÃÖ¿µ·Ï(¼­¿ïÀÇ´ë) 
Åä·Ð 05-21 º£¾î Ȧ 18:00~18:10 ÁúÀÇÀÀ´ä  () 
±³À°½Ã°£ 05-21 º£¾î Ȧ 18:10~18:25 KOTUS-Liver ÀÚ·á ¼öÁý ÇöȲ ¹× °³¼±¹æ¾È  ÀÌÇØ¿ø(¼­¿ïÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹ÀÇÇб³À°ÇÐȸ AME ±âº»ÀÇÇб³À° Á¦µµ¿Í Á¤Ã¥ : 2022-05-21
´ÙÀ½±Û 2022 ûÁÖ½ÃÀÇ»çȸ Ãá°è Çмú´ëȸ : 2022-05-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 11 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 17 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 7 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 18 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 9 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 16 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 9 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 9 2024-05-27
20775 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 1±â(1ÀÏÂ÷) : 2024-06-13 0 18 2024-05-27
20774 ºÎ»ê (¿Â¶óÀÎ) ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³² ÁöºÎȸ 2024³â 06¿ù Çмú´ëȸ : 2024-06-13 0 11 2024-05-27
20773 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç(1ÀÏÂ÷) : 2024-06-13 0 10 2024-05-27
20772 ´ë±¸ 2024 Á¦2Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ´ë±¸°æºÏÁöºÎÇÐȸ : 2024-06-13 0 15 2024-05-27
20771 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-13 0 14 2024-05-27
20770 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-13 0 8 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷